BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 3318384)

  • 1. Acid-ethanol extractable compounds from fruits and seeds of the bitter gourd Momordica charantia: effects on lipid metabolism in isolated rat adipocytes.
    Ng TB; Wong CM; Li WW; Yeung HW
    Am J Chin Med; 1987; 15(1-2):31-42. PubMed ID: 3318384
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peptides with antilipolytic and lipogenic activities from seeds of the bitter gourd Momordica charantia (family Cucurbitaceae).
    Ng TB; Wong CM; Li WW; Yeung HW
    Gen Pharmacol; 1987; 18(3):275-81. PubMed ID: 3106137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening of Trichosanthes kirilowii, Momordica charantia and Cucurbita maxima (family Cucurbitaceae) for compounds with antilipolytic activity.
    Wong CM; Yeung HW; Ng TB
    J Ethnopharmacol; 1985 Jul; 13(3):313-21. PubMed ID: 4058034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin-like molecules in Momordica charantia seeds.
    Ng TB; Wong CM; Li WW; Yeung HW
    J Ethnopharmacol; 1986 Jan; 15(1):107-17. PubMed ID: 3520153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A steryl glycoside fraction from Momordica charantia seeds with an inhibitory action on lipid metabolism in vitro.
    Ng TB; Wong CM; Li WW; Yeung HW
    Biochem Cell Biol; 1986 Aug; 64(8):766-71. PubMed ID: 3021185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isolation and characterization of a galactose binding lectin with insulinomimetic activities. From the seeds of the bitter gourd Momordica charantia (Family Cucurbitaceae).
    Ng TB; Wong CM; Li WW; Yeung HW
    Int J Pept Protein Res; 1986 Aug; 28(2):163-72. PubMed ID: 3533814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIV inhibitor from Thai bitter gourd.
    Jiratchariyakul W; Wiwat C; Vongsakul M; Somanabandhu A; Leelamanit W; Fujii I; Suwannaroj N; Ebizuka Y
    Planta Med; 2001 Jun; 67(4):350-3. PubMed ID: 11458453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Slow acting protein extract from fruit pulp of Momordica charantia with insulin secretagogue and insulinomimetic activities.
    Yibchok-anun S; Adisakwattana S; Yao CY; Sangvanich P; Roengsumran S; Hsu WH
    Biol Pharm Bull; 2006 Jun; 29(6):1126-31. PubMed ID: 16755004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bitter gourd (Momordica charantia) possess developmental toxicity as revealed by screening the seeds and fruit extracts in zebrafish embryos.
    Khan MF; Abutaha N; Nasr FA; Alqahtani AS; Noman OM; Wadaan MAM
    BMC Complement Altern Med; 2019 Jul; 19(1):184. PubMed ID: 31340810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypoglycemic activity of polypeptide-p from a plant source.
    Khanna P; Jain SC; Panagariya A; Dixit VP
    J Nat Prod; 1981; 44(6):648-55. PubMed ID: 7334382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of the enzymatic mechanism of gamma-momorcharin, a novel ribosome-inactivating protein with lower molecular weight of 11,500 purified from the seeds of bitter gourd (Momordica charantia).
    Pu Z; Lu BY; Liu WY; Jin SW
    Biochem Biophys Res Commun; 1996 Dec; 229(1):287-94. PubMed ID: 8954120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retardation of retinopathy by Momordica charantia L. (bitter gourd) fruit extract in alloxan diabetic rats.
    Srivastava Y; Venkatakrishna-Bhatt H; Verma Y; Prem AS
    Indian J Exp Biol; 1987 Aug; 25(8):571-2. PubMed ID: 3446597
    [No Abstract]   [Full Text] [Related]  

  • 13. Purification and characterization of charantin, a napin-like ribosome-inactivating peptide from bitter gourd (Momordica charantia) seeds.
    Parkash A; Ng TB; Tso WW
    J Pept Res; 2002 May; 59(5):197-202. PubMed ID: 11966976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Partially purified bitter gourd (Momordica charantia) peroxidase catalyzed decolorization of textile and other industrially important dyes.
    Akhtar S; Ali Khan A; Husain Q
    Bioresour Technol; 2005 Nov; 96(16):1804-11. PubMed ID: 16051087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of lectins with various carbohydrate binding specificities on lipid metabolism in isolated rat and hamster adipocytes.
    Ng TB; Li WW; Yeung HW
    Int J Biochem; 1989; 21(2):149-55. PubMed ID: 2545472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The complete amino acid sequence of momordin-a, a ribosome-inactivating protein from the seeds of bitter gourd (Momordica charantia).
    Minami Y; Funatsu G
    Biosci Biotechnol Biochem; 1993 Jul; 57(7):1141-4. PubMed ID: 7763984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of protein synthesis in vitro by proteins from the seeds of Momordica charantia (bitter pear melon).
    Barbieri L; Zamboni M; Lorenzoni E; Montanaro L; Sperti S; Stirpe F
    Biochem J; 1980 Feb; 186(2):443-52. PubMed ID: 7378061
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isolation and characterization of a new ribosome inactivating protein, momorgrosvin, from seeds of the monk's fruit Momordica grosvenorii.
    Tsang KY; Ng TB
    Life Sci; 2001 Jan; 68(7):773-84. PubMed ID: 11205869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Draft genome sequence of bitter gourd (Momordica charantia), a vegetable and medicinal plant in tropical and subtropical regions.
    Urasaki N; Takagi H; Natsume S; Uemura A; Taniai N; Miyagi N; Fukushima M; Suzuki S; Tarora K; Tamaki M; Sakamoto M; Terauchi R; Matsumura H
    DNA Res; 2017 Feb; 24(1):51-58. PubMed ID: 28028039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro and in vivo α-amylase and α-glucosidase inhibiting activities of the protein extracts from two varieties of bitter gourd (Momordica charantia L.).
    Poovitha S; Parani M
    BMC Complement Altern Med; 2016 Jul; 16 Suppl 1(Suppl 1):185. PubMed ID: 27454418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.